Teraoka S - Search Results

1

A case of hereditary metachronous bilateral triple-negative breast cancer that was highly sensitive to carboplatin.

Wu R, Adachi K, Koyama Y, Orimoto K, Okazaki M, Asaoka M, Teraoka S, Ueda A, Miyahara K, Kawate T, Kaise H, Yamada K, Sato E, Ishikawa T. Wu R, et al. Among authors: teraoka s. J Surg Case Rep. 2021 Apr 14;2021(4):rjab018. doi: 10.1093/jscr/rjab018. eCollection 2021 Apr. J Surg Case Rep. 2021. PMID: 33884162 Free PMC article.

2

Hereditary breast cancer associated with Cowden syndrome-related PTEN mutation with Lhermitte-Duclos disease.

Kimura F, Ueda A, Sato E, Akimoto J, Kaise H, Yamada K, Hosonaga M, Kawai Y, Teraoka S, Okazaki M, Ishikawa T. Kimura F, et al. Among authors: teraoka s. Surg Case Rep. 2017 Dec;3(1):83. doi: 10.1186/s40792-017-0355-6. Epub 2017 Jul 24. Surg Case Rep. 2017. PMID: 28741261 Free PMC article.

3

Association of BRCA Mutations and BRCAness Status With Anticancer Drug Sensitivities in Triple-Negative Breast Cancer Cell Lines.

Teraoka S, Muguruma M, Takano N, Miyahara K, Kawate T, Kaise H, Yamada K, Miyazawa K, Ishikawa T. Teraoka S, et al. J Surg Res. 2020 Jun;250:200-208. doi: 10.1016/j.jss.2019.12.040. Epub 2020 Feb 21. J Surg Res. 2020. PMID: 32092597

4

Successful treatment of G-CSF-related aortitis with prednisolone during preoperative chemotherapy for breast cancer: a case report.

Koyama Y, Adachi K, Yagi M, Go Y, Orimoto K, Kawai S, Uenaka N, Okazaki M, Asaoka M, Teraoka S, Ueda A, Miyahara K, Kawate T, Kaise H, Yamada K, Ishikawa T. Koyama Y, et al. Among authors: teraoka s. Surg Case Rep. 2021 Jan 14;7(1):23. doi: 10.1186/s40792-021-01111-z. Surg Case Rep. 2021. PMID: 33443626 Free PMC article.

5

Accuracy and validity of sentinel lymph node biopsy for breast cancer using a photosensitizer: 8-year follow-up.

Yamada K, Ogata A, Kaise H, Oda M, Kimura F, Komatsu S, Nakamura Y, Hosonaga M, Matsumura M, Kawate T, Miyahara K, Kawai Y, Ueda A, Teraoka S, Kohno N. Yamada K, et al. Among authors: teraoka s. Lasers Surg Med. 2013 Nov;45(9):558-63. doi: 10.1002/lsm.22183. Epub 2013 Sep 30. Lasers Surg Med. 2013. PMID: 24114757

6

Clinical and pathological predictors of recurrence in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapy.

Asaoka M, Narui K, Suganuma N, Chishima T, Yamada A, Sugae S, Kawai S, Uenaka N, Teraoka S, Miyahara K, Kawate T, Sato E, Nagao T, Matsubara Y, Gandhi S, Takabe K, Ishikawa T. Asaoka M, et al. Among authors: teraoka s. Eur J Surg Oncol. 2019 Dec;45(12):2289-2294. doi: 10.1016/j.ejso.2019.08.001. Epub 2019 Aug 2. Eur J Surg Oncol. 2019. PMID: 31787153

7

Neoadjuvant Chemotherapy With Anthracycline-Based Regimen for BRCAness Tumors in Triple-Negative Breast Cancer.

Teraoka S, Sato E, Narui K, Yamada A, Fujita T, Yamada K, Oba M, Ishikawa T. Teraoka S, et al. J Surg Res. 2020 Jun;250:143-147. doi: 10.1016/j.jss.2019.12.047. Epub 2020 Feb 7. J Surg Res. 2020. PMID: 32044511 Clinical Trial.

8

Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell lines.

Muguruma M, Teraoka S, Miyahara K, Ueda A, Asaoka M, Okazaki M, Kawate T, Kuroda M, Miyagi Y, Ishikawa T. Muguruma M, et al. Among authors: teraoka s. Biochem Biophys Res Commun. 2020 Dec 10;533(3):268-274. doi: 10.1016/j.bbrc.2020.08.075. Epub 2020 Sep 18. Biochem Biophys Res Commun. 2020. PMID: 32958246

9

Absolute Lymphocyte Count, Platelet-to-Lymphocyte Ratio, and Overall Survival in Eribulin-treated HER2-negative Metastatic Breast Cancer Patients.

Koyama Y, Kawai S, Uenaka N, Okazaki M, Asaoka M, Teraoka S, Ueda AI, Miyahara K, Kawate T, Kaise H, Yamada K, Ishikawa T. Koyama Y, et al. Among authors: teraoka s. Cancer Diagn Progn. 2021 Nov 3;1(5):435-441. doi: 10.21873/cdp.10058. eCollection 2021 Nov-Dec. Cancer Diagn Progn. 2021. PMID: 35403160 Free PMC article.

10

β-Tubulin Isoforms Related to Docetaxel Sensitivity in 2D and 3D Cultured TNBC Cell Lines.

Muguruma M, Asaoka M, Teraoka S, Miyahara K, Kawate T, Ishikawa T. Muguruma M, et al. Among authors: teraoka s. Anticancer Res. 2022 Oct;42(10):4735-4742. doi: 10.21873/anticanres.15978. Anticancer Res. 2022. PMID: 36191981

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

414 results

Search Page